Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Som D Mukherjee

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Breast Cancer Research and Treatment|April 2, 2026
Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort studyAmber O Molnar, Eric McArthur, Sarah E Bota, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 PandemicKaren M Zhang, Som D Mukherjee, Gregory Pond, et al.
Physiotherapy Canada. Physiotherapie Canada|March 11, 2024
Evaluating Wall-Mounted Prompts to Facilitate Physical Activity-Related Discussion between Individuals with Cancer and Oncology Health Care Providers: A Pre-post Survey StudyJenna Smith-Turchyn, Som D Mukherjee, Jennifer R Tomasone, et al.
Urologic Oncology|July 17, 2014
Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomyPiotr Zareba, Laurel Patterson, Rishikesh Pandya, et al.
The Lancet. Oncology|May 28, 2013
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 studyYoo-Joung Ko, Christine M Canil, Som D Mukherjee, et al.
Investigational New Drugs|March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancerArun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Breast (Edinburgh, Scotland)|August 4, 2016
Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' viewsMary Ann O'Brien, Miriam Tsao, Sylvie D Cornacchi, et al.
Annals of Surgical Oncology|June 26, 2016
A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast CancerMiriam W Tsao, Sylvie D Cornacchi, Nicole Hodgson, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|April 18, 2022
Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic diseaseSherif Ramadan, Kimmen Quan, Kara Schnarr, et al.
Breast Cancer Research and Treatment|April 2, 2026
Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort studyAmber O Molnar, Eric McArthur, Sarah E Bota, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 PandemicKaren M Zhang, Som D Mukherjee, Gregory Pond, et al.
Physiotherapy Canada. Physiotherapie Canada|March 11, 2024
Evaluating Wall-Mounted Prompts to Facilitate Physical Activity-Related Discussion between Individuals with Cancer and Oncology Health Care Providers: A Pre-post Survey StudyJenna Smith-Turchyn, Som D Mukherjee, Jennifer R Tomasone, et al.
Urologic Oncology|July 17, 2014
Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomyPiotr Zareba, Laurel Patterson, Rishikesh Pandya, et al.
The Lancet. Oncology|May 28, 2013
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 studyYoo-Joung Ko, Christine M Canil, Som D Mukherjee, et al.
Investigational New Drugs|March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancerArun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Breast (Edinburgh, Scotland)|August 4, 2016
Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' viewsMary Ann O'Brien, Miriam Tsao, Sylvie D Cornacchi, et al.
Annals of Surgical Oncology|June 26, 2016
A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast CancerMiriam W Tsao, Sylvie D Cornacchi, Nicole Hodgson, et al.
Pageof 6